A Preclinical Study on 4-Methyl-N-((4-(trifluoromethoxy)phenyl) carbamoyl)-benzenesulfonamide as a Potent Chemotherapeutic Agent against Liver and Pancreatic Carcinogenesis in Rats: Immunohistochemical and Histopathological Studies
The new synthetic medication 3 could be an effective chemotherapeutic method for treating DEN and CCl<sub>4</sub>-induced HCC and pancreatic cancer.
Authors
- Farid M. Sroor (ORCID: https://orcid.org/0000-0003-1283-2157)
- Eman A. Younis (ORCID: https://orcid.org/0000-0002-7753-628X)
- Hanan F. Aly
Institutions
- Institute for the Chemistry of OrganoMetallic Compounds (IT)
- National Research Centre (EG)
Publication Details
- Journal
- Medicinal Chemistry
- Published
- 2024-09-05
- DOI
- https://doi.org/10.2174/0115734064308484240820080153
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16